Foot and Mouth Disease Vaccines Market Size

Foot and Mouth Disease Vaccines Market Size

Foot And Mouth Disease Vaccines Market size was valued at USD 2.5 billion in 2023 and is anticipated to witness growth at a CAGR of 7.7% between 2024 and 2032. The FMD vaccines market is experiencing growth driven by the rising prevalence of foot and mouth disease outbreaks, active involvement of government authorities, and substantial commercialization of livestock products.

To get key market trends

  Download Free Sample

Foot and Mouth Disease (FMD) is a highly contagious viral infection affecting animals such as pigs, cattle, goats, and sheep. The virus belongs to the Picornaviridae family and manifests with symptoms including fever and blisters in the mouth, on the feet, and sometimes on the teats. The substantial prevalence of FMD across the world is a prominent factor accelerating the growth of the market. For instance, according to data published by the World Organization for Animal Health in 2023, the foot and mouth disease virus circulates in an estimated 77% of the global livestock population in regions such as Africa, the Middle East, Asia, and South America. This significant prevalence of the disease is likely to boost routine vaccinations, which will eventually accelerate market growth by 2032.
 

In addition, strategic steps taken by government authorities are expected to further propel the growth of the FMD vaccines market during the forecast period. For instance, in July 2023, the government of Canada announced its plan to develop a full-fledged vaccine bank for foot and mouth disease in livestock. Moreover, in May 2023, the World Bank approved a loan of USD 82 million to support the adoption of global best practices in animal health management for the government of India.
 

Foot and mouth disease vaccines in animals are immunizations designed to protect livestock such as cattle, goats, pigs, sheep, and other cloven-hoofed animals from the highly contagious viral disease caused by the foot and mouth disease virus (FMDV). These vaccines contain inactivated or attenuated strains of the virus, which stimulate the animal's immune system to produce antibodies without causing the disease.